Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RARE - Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q1 2022 Results - Earnings Call Transcript

RARE - Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q1 2022 Results - Earnings Call Transcript

Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical, Inc. (RARE) Q1 2022 Earnings Conference Call May 05, 2022, 17:00 ET Company Participants Joshua Higa - Director, IR & Corporate Communications Emil Kakkis - President, CEO & Director Erik Harris - EVP & Chief Commercial Officer Mardi Dier - EVP & CFO Camille Bedrosian - Chief Medical Officer & EVP Conference Call Participants Huidong Wang - Barclays Bank Yigal Nochomovitz - Citigroup Tazeen Ahmad - Bank of America Merrill Lynch Joel Beatty - Robert W. Baird & Co. Maurice Raycroft - Jefferies Joon So Lee - Truist Securities Brendan Smith - Cowen and Company Dae Gon Ha - Stifel, Nicolaus & Company Jeff Hung - Morgan Stanley Joori Park - SVB Leerink Laura Chico - Wedbush Securities Presentation Operator Good day, and thank you for standing by. Welcome to the Ultragenyx First Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions]. I'd like to hand

For further details see:

Ultragenyx Pharmaceutical, Inc. (RARE) CEO Emil Kakkis on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Ultragenyx Pharmaceutical Inc.
Stock Symbol: RARE
Market: NASDAQ
Website: ultragenyx.com
Menu
RARE RARE Quote RARE Short RARE News RARE Articles RARE Message Board
Get RARE Alerts

News, Short Squeeze, Breakout and More Instantly...